A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.

Descriptor ID	D012642
MeSH Number(s)	D02.092.471.683.915
Concept/Terms	Selegiline Selegiline Selegiline, (R)-Isomer Selegyline L-Deprenyl E-250 E-250 E 250 E250 Eldepryl Eldepryl Emsam Emsam Bristol-Myers Squibb Brand of Selegiline Bristol Myers Squibb Brand of Selegiline Zelapar Zelapar Valeant Brand of Selegiline Selegiline Valeant Brand Selegiline Hydrochloride, (R,S)-Isomer Selegiline Hydrochloride, (R,S)-Isomer Selegiline Hydrochloride, (S)-Isomer Selegiline Hydrochloride, (S)-Isomer Selegiline, (R,S)-Isomer Selegiline, (R,S)-Isomer Deprenil Deprenalin Selegiline, (S)-Isomer Selegiline, (S)-Isomer Yumex Yumex Jumex Humex Deprenyl Deprenyl Selegiline Hydrochloride, (R)-Isomer Selegiline Hydrochloride, (R)-Isomer Selegiline Hydrochloride Hydrochloride, Selegiline

Below are MeSH descriptors whose meaning is more general than "Selegiline".

Below are MeSH descriptors whose meaning is related to "Selegiline".

Below are MeSH descriptors whose meaning is more specific than "Selegiline".